QUINCE THERAPEUTICS INC (QNCX)
US22053A1079 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to QNCX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 9.18. This target is 361.31% above the current price.
QNCX was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about QNCX.
In the previous month the buy percentage consensus was at a similar level.
QNCX was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-02 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-12-18 | Brookline Capital | Initiate | Buy |
| 2024-11-14 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-11-12 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-11-07 | Maxim Group | Initiate | Buy |
| 2024-10-29 | Rodman & Renshaw | Initiate | Buy |
| 2024-10-22 | EF Hutton | Initiate | Buy |